ERIN CORNELIUS: Open Payments
NPI 1073603650 · ARVADA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 71 payments from 35 companies in 2025. Trend: 2023 $377 · 2024 $1,131 · 2025 $1,601
Food & beverage: $1,583Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $190 |
| Biogen, Inc. | 6 | $128 |
| UCB, Inc. | 4 | $104 |
| PFIZER INC. | 4 | $99 |
| Merz Pharmaceuticals, LLC | 3 | $92 |
| GENZYME CORPORATION | 3 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| ANI Pharmaceuticals, Inc. | 3 | $64 |
| EMD Serono, Inc. | 3 | $60 |
| ARGENX US, INC. | 2 | $53 |
Products named: UBRELVY, QULIPTA, QALSODY, PANZYGA, KESIMPTA, Xeomin, PURIFIED CORTROPHIN GEL, BRIUMVI.
Industry payments across CO — which companies pay providers there.
